|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910713508703321 |
|
|
Titolo |
Drug safety: COVID-19 complicates already challenged FDA foreign inspection program : testimony before the Committee on Finance, U.S. Senate / / statement of Mary Denigan-Macauley |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Washington, D.C.] : , : United States Government Accountability Office, , 2020 |
|
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (26 pages) : color illustrations, color maps |
|
|
|
|
|
|
Collana |
|
Testimony ; ; GAO-20-626-T |
|
|
|
|
|
|
Soggetti |
|
COVID-19 (Disease) - Treatment - United States |
Drugs - Inspection - United States |
Drugs - United States - Safety measures - Evaluation |
Pharmaceutical industry - Quality control - Evaluation |
Drugs - Safety regulations - United States - Evaluation |
Drug reimportation - United States - Evaluation |
Imports - United States - Safety measures - Evaluation |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
"For release on delivery, expected at 2:30 p.m. ET, Tuesday, June 2, 2020." |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|